- Home
- XPEL vs INVA Comparison
XPEL vs INVA Comparison
Compare XPEL & INVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XPEL
- INVA
- Stock Information
- Founded
- XPEL 1999
- INVA 1996
- Country
- XPEL United States
- INVA United States
- Employees
- XPEL N/A
- INVA N/A
- Industry
- XPEL Industrial Specialties
- INVA Biotechnology: Pharmaceutical Preparations
- Sector
- XPEL Industrials
- INVA Health Care
- Exchange
- XPEL Nasdaq
- INVA Nasdaq
- Market Cap
- XPEL 991.5M
- INVA 1.2B
- IPO Year
- XPEL N/A
- INVA 2004
- Fundamental
- Price
- XPEL $35.97
- INVA $19.57
- Analyst Decision
- XPEL Strong Buy
- INVA Buy
- Analyst Count
- XPEL 1
- INVA 1
- Target Price
- XPEL $58.00
- INVA $55.00
- AVG Volume (30 Days)
- XPEL 248.6K
- INVA 637.7K
- Earning Date
- XPEL 05-06-2025
- INVA 05-07-2025
- Dividend Yield
- XPEL N/A
- INVA N/A
- EPS Growth
- XPEL N/A
- INVA N/A
- EPS
- XPEL 1.71
- INVA N/A
- Revenue
- XPEL $434,101,000.00
- INVA $369,844,000.00
- Revenue This Year
- XPEL $11.20
- INVA $3.75
- Revenue Next Year
- XPEL $11.18
- INVA $12.62
- P/E Ratio
- XPEL $20.97
- INVA N/A
- Revenue Growth
- XPEL 8.38
- INVA 18.70
- 52 Week Low
- XPEL $24.25
- INVA $15.32
- 52 Week High
- XPEL $48.58
- INVA $21.28
- Technical
- Relative Strength Index (RSI)
- XPEL 57.00
- INVA 71.81
- Support Level
- XPEL $35.62
- INVA $18.59
- Resistance Level
- XPEL $36.67
- INVA $19.08
- Average True Range (ATR)
- XPEL 1.12
- INVA 0.39
- MACD
- XPEL -0.29
- INVA 0.08
- Stochastic Oscillator
- XPEL 31.95
- INVA 94.89
About XPEL XPEL Inc.
XPEL Inc is a supplier of protective films, coatings, and related services to the automobile aftermarket, new car dealerships, and automobile original equipment manufacturers, or OEMs. The majority of its revenue is derived from the sale of automotive products and related services while the remainder of its revenue is derived from non-automotive products including architectural window film and marine and flat surface protection films. The majority of revenue is derived from the United States.
About INVA Innoviva Inc.
Innoviva Inc is a company with a portfolio of royalties healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.